---
title: "Barclays Adjusts Price Target on Vertex Pharmaceuticals to $467 From $435, Maintains Equalweight Rating"
date: "2025-02-11 19:34:56"
summary: "Vertex Pharmaceuticals  has an average rating of overweight and mean price target of $507.46, according to analysts polled by FactSet."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Vertex Pharmaceuticals has an average rating of overweight and mean price target of $507.46, according to analysts polled by FactSet.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250211:A3314185:0/)
